Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgical Treatment of Aortic Valve Disease With Moderate Functional Mitral Regurgitation

NCT05566340 is registered in ClinicalTrials.gov with Fuwai Yunnan Cardiovascular Hospital as lead sponsor.

NCT NCT05566340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05566340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgical Treatment of Aortic Valve Disease With Moderate Functional Mitral Regurgitation
Lead sponsor
Fuwai Yunnan Cardiovascular Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2022
Completion date
December 31, 2023
Enrollment
154 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation